News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Researchers at the University of York are using light-based technology to develop a simple and cost-effective blood test for Alzheimer’s disease.

Clinical Trial Authorisation application granted for combined drug PK051 targeting amyloid deposits associated with Alzheimer’s Disease

PharmaKure submits MHRA CTA for Phase 2a Clinical Trial of PK051 in patients with mild cognitive impairment Clinical Trial Application filed for combined drug targeting amyloid deposits as...

PharmaKure, a company specialising in companion diagnostics for the treatment of neurological diseases and APIS Assay Technologies Ltd, a company with scientific expertise in biomarker trans...

PharmaKure has launched a study to examine the relationship between blood biomarkers and historical PET scans or CSF in patients with Mild Cognitive Impairment due to Alzheimer’s Disease.

University of Liverpool working with collaborators at UCLAN, Lancaster University, University of Bradford, and UCL are investigating the wider national picture of the effects of social care ...

Psychiatry Consortium to address unmet patient needs

Our Valued Sponsors & Partners